Protelos® significantly reduces non vertebral fracture risk in postmenopausal women with osteoporosis

The results of the TROPOS (Treatment of Peripheral Osteoporosis) study, published today in the Journal of Clinical Endocrinology and Metabolism show that strontium ranelate (Protelos®) significantly reduces the risk of all non vertebral and, in a high risk group, hip fractures over three years.

Recent Blog Post

The Link Between Gut Viruses and Cardiometabolic Disease 

21st February 2024 – By TwinsUK A recent review published by researchers at TwinsUK sheds light on the potential role...

The gut microbiome can predict treatment response in rheumatoid arthritis

Monday 19th February – by King’s College London Professor Frances Williams’ chronic pain research group within TwinsUK at King’s College...

MRI scanner and researchers

TwinsUK Twins Undergo First MRI Scan in New Study on Healthy Ageing 

19th January 2024 – By Aaruthy Suthahar TwinsUK and the School of Biomedical Engineering & Imaging Sciences at King’s College...